+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo



Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo



Urology 48(1): 164-170




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 031079945

Download citation: RISBibTeXText

PMID: 8693645

DOI: 10.1016/s0090-4295(96)00109-4


Related references

Inhibition of prostate cancer growth by estramustine and etoposide. Cancer (philadelphia). 75(7 Suppl.): -1926, 1995

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary results. International Journal of Radiation Oncology Biology Physics 49(3): 699-703, 2001

Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix. Journal of Urology 149(6): 1622-1625, 1993

Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. Clinical Cancer Research 3(11): 2039-2046, 1997

Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancer. Journal of Clinical Oncology 13(3): 797, 1995

A randomized phase II study of estramustine phosphate versus estramustine phosphate plus etoposide in hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology 26(15_Suppl): 20632-20632, 2016

Cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines TGF-beta modulation and expression of cell cycle control genes. European Urology 36(5): 518-519, 1999

The nuclear matrix as a target for prostate cancer chemotherapy estramustine and etoposide interact at the level of the nuclear matrix to inhibit prostate cancer growth. Journal of Cellular Biochemistry Suppl. (16 Part D): 98, 1992

Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol. Medical Oncology 20(1): 29-35, 2003

Effect of CKBM on prostate cancer cell growth in vitro and in vivo. Journal of ChemoTherapy 20(2): 246-252, 2008

Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo. International Journal of Cancer 121(6): 1197-1204, 2007

Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 22(3): 225-233, 1993

Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer. Seminars in Oncology 24(5 Suppl 15): S15, 1997

Phase I/II trial of weekly taxol and estramustine in patients with hormone-refractory prostate cancer. Cancer Investigation 18(Suppl. 1): 80-81, 2000

Combined antimicrotubule activity of estramustine and taxol in human prostate carcinoma cell lines. Cellular Pharmacology 1(Suppl. 1): S118, 1993